Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers-Reference-Cited by-同舟云学术

Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers

Published:2005-02-12 Issue:2 Volume:61 Page:103-111
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Valle M.,Barbanoj M. J.,Donner A.,Izquierdo I.,Herranz U.,Klein N.,Eichler H. G.,Müller M.,Brunner M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-004-0887-0.pdf

Reference29 articles.

1. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21(2):195–218

2. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer’s disease: a review of 17 epidemiologic studies. Neurology 47(2):425–432

3. Mackenzie IR, Hao C, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol Aging 16(5):797–804

4. McNeely W, Goa KL (1998) Triflusal. Drugs 55(6):823–833

5. García Rafanell J, Planas JM, Puig Parellada P (1979) Comparison of the inhibitory effects of acetylsalicylic and triflusal on enzymes related to thrombosis. Arch Int Pharmacodyn Ther 237(2):343–350

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of an LC-MS/MS Method to a Urinary Excretion Study of Triflusal and its Main Metabolite 2-hydroxy-4-trifluoromethyl Benzoic Acid in Human Urine;Current Pharmaceutical Analysis;2020-03-31

2. Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder;European Journal of Clinical Pharmacology;2018-12-15

3. Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain;Neuroscience Letters;2017-03

4. Population pharmacokinetic and pharmacodynamic modeling of transformed binary effect data of triflusal in healthy Korean male volunteers: a randomized, open-label, multiple dose, crossover study;BMC Pharmacology and Toxicology;2014-12

5. A novel synthetic HTB derivative, BECT inhibits lipopolysaccharide-mediated inflammatory response by suppressing the p38 MAPK/JNK and NF-κB activation pathways;Pharmacological Reports;2014-06